Histogenics Corporation Proudly Supports the Major League Soccer Medical Symposium to Raise Awareness on Sports-Related Injuries
1/10/2013 9:40:17 AM
More...
|
Kevin Rakin Appointed to the Histogenics Corporation Board of Directors
12/3/2012 10:47:12 AM
More...
|
Histogenics Corporation Selects ImageIQ to Provide Imaging Analysis for Phase 3 Clinical Trial
7/26/2012 10:18:21 AM
More...
|
Histogenics Corporation Selects ImageIQ to Provide Imaging Analysis for Phase 3 Clinical Trial
7/26/2012 9:18:14 AM
More...
|
Histogenics Corporation Brings In $49 Million for Tissue Regeneration - and Recapitalization
7/24/2012 7:22:51 AM
More...
|
Histogenics Corporation Announces Publication in Journal of Bone and Joint Surgery Demonstrating that NeoCart® is Associated With Greater Clinical Efficacy Two Years After Treatment than Current Standard of Care, Microfracture Surgery
6/6/2012 2:01:05 PM
More...
|
Histogenics Corporation’ NeoCart for Patients with Knee Cartilage Damage Demonstrates Continued Efficacy for Periods of Up to Five Years
5/14/2012 10:10:29 AM
More...
|
Histogenics Corporation to Present at 7th Annual New York Stem Cell Summit
2/17/2012 6:33:44 AM
More...
|
Histogenics Corporation to Present at Canaccord Adams Genuity Musculoskeletal Conference
2/3/2012 6:38:03 AM
More...
|
Histogenics Corporation Appoints Scientific Advisory Board Comprised of Regenerative Medicine Leaders
10/12/2011 10:20:51 AM
More...
|
|